Abstract:Chronic osteomyelitis is a challenging disease due to its serious rates of mortality and morbidity while the currently available treatment strategies are suboptimal. In contrast to the adopted systemic treatment approaches after surgical debridement in chronic osteomyelitis, local drug delivery systems are receiving great attention in the recent decades. Local drug delivery systems using special carriers have the pros of enhancing the feasibility of penetration of antimicrobial agents to bone tissues, providing sustained release and localized concentrations of the antimicrobial agents in the infected area while avoiding the systemic side effects and toxicity. Most important, the incorporation of osteoinductive and osteoconductive materials in these systems assists bones proliferation and differentiation, hence the generation of new bone materials is enhanced. Some of these systems can also provide mechanical support for the long bones during the healing process. Most important, if the local systems are designed to be injectable to the affected site and biodegradable, they will reduce the level of invasion required for implantation and can win the patients' compliance and reduce the healing period. They will also allow multiple injections during the course of therapy to guard against the side effect of the long-term systemic therapy. The current review presents different available approaches for delivering antimicrobial agents for the treatment of osteomyelitis focusing on the recent advances in researches for local delivery of antibiotics.HIGHLIGHTSChronic osteomyelitis is a challenging disease due to its serious mortality and morbidity rates and limited effective treatment options.Local drug delivery systems are receiving great attention in the recent decades.Osteoinductive and osteoconductive materials in the local systems assists bones proliferation and differentiationLocal systems can be designed to provide mechanical support for the long bones during the healing process.Designing the local system to be injectable to the affected site and biodegradable will reduces the level of invasion and win the patients' compliance.

Evolving concepts in bone infection: redefining “biofilm”, “acute vs. chronic osteomyelitis”, “the immune proteome” and “local antibiotic therapy”

Infectious Osteomyelitis: Marrying Bone Biology and Microbiology to Shed New Light on a Persistent Clinical Challenge

Skeletal infections: microbial pathogenesis, immunity and clinical management

Bacterial biofilm and chronic osteomyelitis

Advances in the local and targeted delivery of anti-infective agents for management of osteomyelitis

Staphylococcus aureus Osteomyelitis: Bone, Bugs, and Surgery

Emerging electron microscopy and 3D methodologies to interrogate Staphylococcus aureus osteomyelitis in murine models

Osteomyelitis: a current challenge

Prospects and challenges for the application of tissue engineering technologies in the treatment of bone infections

Advances in the targeted theragnostics of osteomyelitis caused by Staphylococcus aureus

Flourishing Antibacterial Strategies for Osteomyelitis Therapy

Nanotechnology in the Diagnosis and Treatment of Osteomyelitis

Current application and future perspectives of antimicrobial degradable bone substitutes for chronic osteomyelitis

Innovations in osteomyelitis research: A review of animal models

Antibiotic-eluting scaffolds with responsive dual-release kinetics facilitate bone healing and eliminate S. aureus infection

Current therapeutic interventions combating biofilm-related infections in orthopaedics

Mechanisms of Antibiotic Failure During Staphylococcus aureus Osteomyelitis

The effect of Staphylococcus aureus on innate and adaptive immunity and potential immunotherapy for S. aureus-induced osteomyelitis

Current therapeutic interventions combating biofilm-related infections in orthopaedics : a systematic review of in vivo animal studies

Recent advances in the local antibiotics delivery systems for management of osteomyelitis

Evading the host response: Staphylococcus “hiding” in cortical bone canalicular system causes increased bacterial burden